European Medicines Agency

Global markets face volatility amid inflation and rate fears

17 clusters · 177 sources · last updated about 3 hours ago

Latest: Oil prices rise globally amid U.S. inflation concerns

By early September, global markets showed positive movement as investors reacted to shifting interest rate expectations. However, by the week of September 6, significant volatility emerged as investors weighed rising oil

Poland COVID-19 vaccination guidelines 2026/2027

3 clusters · 9 sources · last updated 1 day ago

Latest: Poland launches 2026/2027 COVID-19 vaccination campaign

The Polish Ministry of Health has established guidelines and initiated the 2026/2027 COVID-19 vaccination campaign. The program provides free vaccinations for eligible individuals, with the state budget funding procureme

Migraine prevalence and treatment challenges

2 clusters · 12 sources · last updated 3 days ago

Latest: Mexico Senate calls for improved migraine diagnosis and treatment

Recent reports from Spain and Mexico highlight the significant public health burden and systemic challenges associated with migraine prevalence. In Spain, the Spanish Society of Neurology (SEN) previously reported that

GLP-1 obesity drug rollout and market expansion

105 clusters · 510 sources · last updated 3 days ago

Latest: Novo Nordisk reports pediatric obesity trial success amid market pressure

Novo Nordisk continues to expand its GLP-1 market presence, maintaining approximately a 43% global market share for obesity and diabetes treatments despite competition from Eli Lilly. The oral Wegovy pill remains a prima

Expanded therapeutic research on metformin and semaglutide

12 clusters · 95 sources · last updated 4 days ago

Latest: Scientific studies explore grapes and semaglutide for longevity

Recent medical research has identified expanded therapeutic potential for diabetes and obesity medications, specifically metformin and semaglutide, regarding brain health, organ function, and aging. Studies from Baylor C

EU initiatives to reduce animal testing

2 clusters · 14 sources · last updated 4 days ago

Latest: Germany reports decline in animal testing as EU seeks alternatives

The European Union is advancing efforts to reduce reliance on animal testing through regulatory initiatives and shifting research methodologies. The European Medicines Agency (EMA) launched the Voluntary Data Submission

Clinical applications and access of CAR-T cell therapy

5 clusters · 14 sources · last updated 6 days ago

Latest: CAR-T cell therapy advances in cancer treatment and insurance coverage

CAR-T cell therapy is demonstrating expanding clinical utility across oncology and autoimmune diseases. In oncology, the therapy is transforming treatment for aggressive lymphomas, specifically for patients with refracto

Global Cancer Burden and Rising Projections through 2050

8 clusters · 46 sources · last updated 7 days ago

Latest: Global cancer cases projected to rise 67% by 2050

The global cancer crisis continues to escalate, with the World Health Organization noting that new cases are expected to rise by 70% over the next two decades. In 2024, the International Agency for Research on Cancer (IA

Advancements in HER2-positive cancer treatments

3 clusters · 7 sources · last updated 11 days ago

Latest: European Commission approves new HER2-positive breast cancer treatment

Regulatory bodies have issued new approvals for treatments targeting HER2-positive cancers. In late August 2026, the European Medicines Agency (EMA) issued a positive opinion for using trastuzumab deruxtecan in combinati

European authorization of Hopledo for Parkinson's disease

2 clusters · 18 sources · last updated 12 days ago

Latest: Medical research advances in cancer and Parkinson's disease

The European Commission and the European Medicines Agency (EMA) have authorized Hopledo, a modified-release oral formulation of levodopa/carbidopa, for the treatment of adult patients with Parkinson’s disease. The thera

Tavneos drug recall in Europe

2 clusters · 6 sources · last updated 13 days ago

Latest: Tavneos drug recalled in Hungary following EU safety concerns

The prescription drug Tavneos, used to treat rare autoimmune inflammatory vascular diseases, is being withdrawn from European markets following safety concerns. In August 2026, the French National Agency for the Safety

Health benefits and medicinal uses of lemon balm

2 clusters · 4 sources · last updated 18 days ago

Latest: Lemon balm extracts may reduce anxiety and benign palpitations

Lemon balm (Melissa officinalis) is recognized for various health benefits, particularly in reducing stress, anxiety, and improving sleep quality. It has also been noted for potential cardiovascular benefits, such as red

Growth and regulation in pharmaceutical cold chain logistics

3 clusters · 7 sources · last updated 18 days ago

Latest: Pharmaceutical logistics transform to handle temperature-sensitive drugs

The pharmaceutical logistics sector is expanding due to a rising demand for temperature-sensitive medical treatments, particularly biologics and GLP-1 medications used for diabetes and obesity. In the United States, Fed

BPC-157 peptide research and regulatory status

2 clusters · 2 sources · last updated 18 days ago

Latest: BPC-157 peptide researched for tissue regeneration and recovery

BPC-157 is a synthetic peptide derived from a protein found in gastric juice that has become a subject of interest in medical research and biohacking communities. Research suggests the compound may support the regenerati

HSE approves Skyclarys reimbursement for patients

5 clusters · 12 sources · last updated 20 days ago

Latest: HSE approves Skyclarys reimbursement for Friedreich’s Ataxia patients

The HSE Drugs Group had previously recommended against state funding for Skyclarys, a treatment for Friedreich’s ataxia, citing high costs of approximately €280,000 per patient annually. While the drug is approved by the

Peru Ministry of Health administrative and tech crisis

3 clusters · 19 sources · last updated 21 days ago

Latest: Global healthcare sectors address infrastructure and technology gaps

Peru’s Minister of Health, Luis Dyer Fernández, has characterized the administrative state of the Ministry of Health (MINSA) as “catastrophic.” The minister noted that the ministry’s technology is comparable to the mid-1

Wegovy medication usage and patient experiences

2 clusters · 4 sources · last updated 28 days ago

Latest: Weight loss medication users discuss Wegovy and Mounjaro experiences

Wegovy, a semaglutide-based prescription medication developed by Novo Nordisk, is used to treat obesity and overweight conditions by mimicking the GLP-1 hormone to regulate blood sugar and increase satiety. While it shar